Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • Gilead stock drops amid mixed results on drug remdesivir’s effects on virus
01 Jun

Gilead stock drops amid mixed results on drug remdesivir’s effects on virus

By admin 0 Comments

Company-led study finds those who who got medication for 5 days improved 65%, while there was no proven difference when getting it for 10 days; more details to be published

Details
Vote up!
Vote down!

Points: 37

Category: 
Israel & the Region
coronavirus
COVID-19
remdesivir
Gilead Sciences Inc.
  • Log in or register to post comments

Author

anon

admin

Hot

  • “Not a Good Use of Money”: Majority of Americans Disapprove of Trump’s Costly Army/Birthday Parade, Poll Finds
  • DRAMA: Chareidi Lawmakers’ Meeting with Knesset Legal Adviser Ends in Blowup
  • Israeli Synagogues to Close This Shabbat for First Time Since COVID

User login

  • Create new account
  • Request new password

Recent comments

No comments available.